蒲地蓝消炎口服液治疗病毒性角膜炎临床观察

Clinical Observation on Pudilan Anti-inflammatory Oral Liquid for Treating Viral Keratitis

目的:蒲地蓝消炎口服液治疗病毒性角膜炎的临床治疗效果。方法:将收集的于2009年1月至2012年8月来我院就治的病毒性角膜炎患者随机分为治疗组和对照组,其中对照组26例(30只眼),采用西药治疗;治疗组28例(30只眼),在采用西医治疗的基础上加用蒲地蓝消炎口服液治疗。2组患者均以1个月为1个疗程,1个月治疗结束后。结果:治疗组临床治愈率以及总有效均明显高于对照组(P<0.05);治疗组治疗后的视力恢复情况优于对照组(P<0.05)。结论:蒲地蓝消炎口服液可以有效的治疗病毒性角膜炎。

Objective：To observe clinic treatment effect of Pudilan anti-inflammatory oral liquid in treating viral keratitis.Methods：Out patients of keratitis from January 2009 to August 2012 were randomized to a control group of 26 cases of（30 eyes）,using Western medicine,and the integrated Chinese and western medicine group of 28 cases（30 eyes）,using both Western medicine and Pudilan anti-inflammatory oral liquid.The duration was a month.Results：Clinical curative rate and total effective rate of the integrated group was significantly higher than that of the control group（P 0.05）.The prognosis of integrated group was better than the control group（P 0.05）.Conclusion：Pudilan anti-inflammatory oral liquid can be effective for treatment of viral keratitis.